Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Q1 2024 Oncology Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q1 2024 Oncology Update

Oncology practice management continues to be one of the most active spaces in healthcare M&A, as evidenced by the continued level of transaction activity in Q1 2024. Provident expects interest to remain strong among the investor community as our attendance at the Community Oncology Conference (COA) in early April 2024 confirmed this viewpoint across a number of industry stakeholders. Strategic acquirers such as AON, OO and USON have continued their rapid expansion, as shown by their dominance of Q1 2024 transaction activity. It is Provident’s expectation that there will be at least one new Oncology platform developed in 2024, which will further drive competition for add-on acquisitions. The larger buyer pool will provide independent practices which may not be platform caliber the opportunity to explore another partner option. Additionally, there will be several larger practices who transact in 2024, which will create tremendous interest among the investor community. If we were not able to connect at COA, please reach out and we would welcome further discussion.

To print and download the full Oncology Services Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/04/Q1-2024-Oncology-Newsletter.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]